Outcome Of Board Meeting Held On 14.08.2018
Outcome of Board meeting held on 14.08.201814-08-2018
Closure of Trading Window
Closure of Trading Window for the un-audited financial results for the quarter ended 30.06.201802-08-2018
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14.08.2018
CONCORD DRUGS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve 1. Un-audited financial results for the quarter ended 30.06.2018 2. To fix the day, date, time and venue of the ensuing Annual General Meeting of the Company. 3. Any other business with the permission of the Chair.02-08-2018
Shareholding for the Period Ended June 30, 2018
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here20-07-2018
Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- KONI REDDY SEELAM Designation :- Director16-07-2018
Audited Financial Results For The Quarter And Year Ended 31.03.2018
Audited financial results for the quarter and year ended 31.03.201801-06-2018
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Appointment of statutory auditors25-05-2018
Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
Resignation of Statutory Auditor23-05-2018